EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Paucigranulocytic Asthma in Aspirin‐Hypersensitive Patients: Pleiotropic Regulation of Type 2 Biomarkers

Radosław Kacorzyk, Piotr Szatkowski, Agnieszka Gawlewicz-Mroczka, Adam Ćmiel, Anna Gielicz iD, Adam Stępień, Patryk Hartwich, Marek Sanak iD, Lucyna Mastalerz iD

Clinical and Translational Allergy · 2026-07 · 16 (7)

DOI: 10.1002/clt2.70186 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical and Translational Allergy, online erschienen am 19.07.2026. Verfasst von Radosław Kacorzyk und 8 weiteren Autor:innen. Beteiligte Einrichtung: 2nd Department of Internal Medicine, Jagiellonian University Medical College, Krakow, Poland. Die Arbeit nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Narodowe Centrum Nauki, Jagiellonian University Medical College, under the Visibility & Mobility Module within the Excellence Initiative at Jagiellonian University (ID.UJ).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Up to 50% of patients with nonsteroidal anti‐inflammatory drug‐exacerbated respiratory disease (N‐ERD) exhibit a noneosinophilic airway inflammatory phenotype, with paucigranulocytic asthma being the most prevalent. The aim was to identify clusters within N‐ERD and aspirin‐tolerant asthma (ATA) controls with a paucigranulocytic asthma phenotype.

Methods

Two separate hierarchical cluster analyses were performed using 23 variables in 36 N‐ERD patients and 19 ATA controls. Variables included demographic, clinical, treatment‐related, and hematologic parameters; sputum cytology; sinus computed tomography findings; and eicosanoid levels in induced sputum supernatant (ISS) and urine.

Results

Two clusters were identified in each group: 1 N‐ERD , 2 N‐ERD , 1 ATA , and 2 ATA . Cluster 1 N‐ERD patients had less severe asthma and required lower doses of inhaled corticosteroids (ICS) but showed higher blood eosinophil counts, Lund‐Mackay (LM) scores, and ISS leukotriene E 4 (LTE 4 ) levels than those in cluster 2 N‐ERD . Cut‐off values defining a T2‐high paucigranulocytic asthma profile in N‐ERD included LM score ≥ 18, blood eosinophils ≥ 300 cells/mm 3 , and ISS LTE 4 ≥ 30 pg/mL, with the LM score demonstrating the highest AUC at 0.8. Among ATA controls, cluster 1 ATA had more severe asthma, higher ICS doses, more severe sinonasal disease, and increased ISS leukotriene D 4 and LTE 4 levels compared with cluster 2 ATA .

Conclusion

Two clusters were identified among N‐ERD patients with a paucigranulocytic asthma phenotype. Cluster 1 N‐ERD was characterized by milder asthma, more severe sinonasal disease, elevated blood eosinophil counts, and elevated ISS LTE 4 . This T2‐high‐like cluster may represent a subgroup requiring further evaluation for anti‐T2 biologic therapy targeting chronic rhinosinusitis with nasal polyps, although further validation is required.

Schlagwörter

Stichwörter der Autor:innen

cluster analysisinduced sputumnonsteroidal anti‐inflammatory drug–exacerbated respiratory diseasepaucigranulocytic inflammatory phenotype

Autor:innen und Institutionen

  • 2nd Department of Internal Medicine, Jagiellonian University Medical College, Krakow, Poland.
  • Doctoral School of Medical and Health Sciences, Jagiellonian University Medical College, Krakow, Poland.
  • Department of Applied Mathematics, AGH University of Science and Technology, Krakow, Poland.
  • Department of Otolaryngology, Jagiellonian University Medical College, Krakow, Poland.

ORCID-Profile: Anna Gielicz, Marek Sanak, Lucyna Mastalerz

Förderung

  • Narodowe Centrum Nauki
  • Jagiellonian University Medical College, under the Visibility & Mobility Module within the Excellence Initiative at Jagiellonian University (ID.UJ)

Zitieren

APA

Kacorzyk, R., Szatkowski, P., Gawlewicz-Mroczka, A., Ćmiel, A., Gielicz, A., Stępień, A., Hartwich, P., Sanak, M., & Mastalerz, L. (2026). Paucigranulocytic Asthma in Aspirin‐Hypersensitive Patients: Pleiotropic Regulation of Type 2 Biomarkers. Clinical and Translational Allergy, 16(7). https://doi.org/10.1002/clt2.70186

Vancouver

Kacorzyk R, Szatkowski P, Gawlewicz-Mroczka A, Ćmiel A, Gielicz A, Stępień A, et al. Paucigranulocytic Asthma in Aspirin‐Hypersensitive Patients: Pleiotropic Regulation of Type 2 Biomarkers. Clinical and Translational Allergy. 2026;16(7). doi:10.1002/clt2.70186

BibTeX
@article{Kacorzyk2026,
  author = {Kacorzyk, Radosław and Szatkowski, Piotr and Gawlewicz-Mroczka, Agnieszka and Ćmiel, Adam and Gielicz, Anna and Stępień, Adam and Hartwich, Patryk and Sanak, Marek and Mastalerz, Lucyna},
  title = {Paucigranulocytic Asthma in Aspirin‐Hypersensitive Patients: Pleiotropic Regulation of Type 2 Biomarkers},
  journal = {Clinical and Translational Allergy},
  year = {2026},
  volume = {16},
  number = {7},
  doi = {10.1002/clt2.70186}
}
Kostenlos starten →